Edition:
United States

Critical Outcome Technologies Inc (COT.V)

COT.V on TSX Venture Exchange

1.18CAD
--
Change (% chg)

-- (--)
Prev Close
$1.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,233
52-wk High
$6.60
52-wk Low
$1.01

Chart for

About

Critical Outcome Technologies Inc. (COTI) is a clinical-stage biopharmaceutical company. The Company is engaged in drug discovery and development. The Company uses machine learning to develop targeted therapies thereby managing the timeline and cost of getting new drug therapies to market. The Company's artificial intelligence... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $17.60
Shares Outstanding(Mil.): 14.92
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.38 16.25
EPS (TTM): -- -- --
ROI: -- 2.96 14.87
ROE: -- 4.74 13.89

BRIEF-Critical Outcome Technologies closes $1.5 mln private placement

* Critical Outcome Technologies closes $1.5 mln private placement Source text for Eikon: Further company coverage:

Sep 20 2017

BRIEF-Critical Outcome Technologies announces Q4 loss per share C$0.13

* Critical Outcome Technologies announces fourth quarter and full year 2017 financial results

Aug 28 2017

BRIEF-Critical Outcome Technologies completes phase 1 dose escalation portion of COTI-2 trial

* Critical Outcome Technologies completes phase 1 dose escalation portion of COTI-2 trial in gynecological malignancies

Aug 14 2017

BRIEF-Critical Outcome Technologies appoints chief scientific officer

* Critical Outcome Technologies appoints experienced biotech leader as chief scientific officer Source text for Eikon: Further company coverage:

May 11 2017

Earnings vs. Estimates